Our findings indicate that knockdown or overexpression of LncRNA DUXAP8 directly influenced the A549 cells’ viability, which further implied LncRNA DUXAP8 could regulate cell proliferation and migration and become a potential disease biomarker for the screening and early diagnosis of NSCLC. Here, DUXAP8 is linked to non-small cell lung carcinoma.